Qualcomm Stock: 5G Leader at a Bargain Price?
Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…
Sell
50
GSK Quote, Financials, Valuation and Earnings
Last price:
$39.49
Seasonality move
:
4.92%
Day range:
$39.05 - $39.61
52-week range:
$31.72 - $45.93
Dividend yield:
3.94%
P/E ratio:
24.94x
P/S ratio:
2.04x
P/B ratio:
4.69x
Volume:
4.9M
Avg. volume:
5.7M
1-year change:
-8.33%
Market cap:
$80.5B
Revenue:
$40.1B
EPS (TTM):
$1.58
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.3B | $34B | $36.3B | $37.7B | $40.1B | |
| Revenue Growth (YoY) | -27.48% | 8.7% | 6.88% | 3.92% | 6.26% | |
| Cost of Revenues | $10.2B | $11.2B | $11.8B | $10.7B | $11.6B | |
| Gross Profit | $21.1B | $22.7B | $24.5B | $27.1B | $28.5B | |
| Gross Profit Margin | 67.44% | 66.95% | 67.42% | 71.76% | 71.16% | |
| R&D Expenses | $6.2B | $6.9B | $6.8B | $7.7B | $8.2B | |
| Selling, General & Admin | $9.5B | $9.7B | $10.4B | $11.7B | $14.1B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $15.2B | $16B | $16.1B | $17.9B | $21.5B | |
| Operating Income | $5.9B | $6.7B | $8.3B | $9.1B | $7.1B | |
| Net Interest Expenses | $1.1B | $1B | $1B | $914.6M | $770.7M | |
| EBT. Incl. Unusual Items | $6.6B | $5B | $7B | $7.5B | $4.4B | |
| Earnings of Discontinued Ops. | $1.6B | $2.2B | $13.3B | -- | -- | |
| Income Tax Expense | $86M | $114.2M | $875.5M | $940.7M | $672.2M | |
| Net Income to Company | $6.5B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Minority Interest in Earnings | -$820.1M | -$978.2M | -$823.5M | -$472.8M | -$480.5M | |
| Net Income to Common Excl Extra Items | $7.4B | $6B | $18.5B | $6.1B | $3.3B | |
| Basic EPS (Cont. Ops) | $3.71 | $3.02 | $9.20 | $3.03 | $1.62 | |
| Diluted EPS (Cont. Ops) | $3.66 | $2.98 | $9.07 | $2.98 | $1.59 | |
| Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $2B | $2B | $2.1B | $2.1B | |
| EBITDA | $10.4B | $8.9B | $10.7B | $11.3B | $8.5B | |
| EBIT | $7.7B | $6B | $8B | $8.4B | $5.3B | |
| Revenue (Reported) | $31.3B | $34B | $36.3B | $37.7B | $40.1B | |
| Operating Income (Reported) | $5.9B | $6.7B | $8.3B | $9.1B | $7.1B | |
| Operating Income (Adjusted) | $7.7B | $6B | $8B | $8.4B | $5.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -$1.3B | $9.5B | $8.7B | $10B | $10.4B | |
| Revenue Growth (YoY) | -- | -- | -9.07% | 15.3% | 3.92% | |
| Cost of Revenues | -$796.9M | $3.8B | $2.6B | $3B | $3.3B | |
| Gross Profit | -$530.4M | $5.8B | $6B | $7B | $7.1B | |
| Gross Profit Margin | 39.96% | 60.64% | 69.66% | 69.97% | 68.47% | |
| R&D Expenses | $1.5B | $1.9B | $2.1B | $2.5B | $2.6B | |
| Selling, General & Admin | -$1.1B | $3B | $2.9B | $3.3B | $3.4B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.3B | $4.4B | $3.5B | $5.5B | $4.3B | |
| Operating Income | -$2.8B | $1.4B | $2.5B | $1.5B | $2.8B | |
| Net Interest Expenses | $314M | $252.1M | $314M | $311.7M | $249.7M | |
| EBT. Incl. Unusual Items | -$1.3B | $408.5M | $1.9B | $470.7M | $720.8M | |
| Earnings of Discontinued Ops. | -- | $687.5M | -$5.9M | -- | -- | |
| Income Tax Expense | -$700.6M | -$157.7M | $1.2M | -$23.6M | $79.4M | |
| Net Income to Company | -$621.2M | $568.4M | $2.2B | $387.5M | $583.5M | |
| Minority Interest in Earnings | -$213.7M | -- | -$147M | -$59.6M | -$111.4M | |
| Net Income to Common Excl Extra Items | $893.3M | $295.2M | $1.8B | $434.7M | $530.1M | |
| Basic EPS (Cont. Ops) | $0.45 | $0.51 | $0.87 | $0.21 | $0.26 | |
| Diluted EPS (Cont. Ops) | $0.44 | $0.50 | $0.86 | $0.21 | $0.26 | |
| Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $2B | $2B | $2.1B | $2.1B | |
| EBITDA | $2.1B | $1.1B | $2.2B | $1.4B | $1.4B | |
| EBIT | -$1B | $653.8M | $2.2B | $663.2M | $905.2M | |
| Revenue (Reported) | -$1.3B | $9.5B | $8.7B | $10B | $10.4B | |
| Operating Income (Reported) | -$2.8B | $1.4B | $2.5B | $1.5B | $2.8B | |
| Operating Income (Adjusted) | -$1B | $653.8M | $2.2B | $663.2M | $905.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31B | $37.1B | $36.2B | $37.7B | $40.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.1B | $12.3B | $11.9B | $10.7B | $11.6B | |
| Gross Profit | $20.9B | $24.7B | $24.4B | $27.1B | $28.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.1B | $7B | $6.7B | $7.7B | $8.2B | |
| Selling, General & Admin | $9.4B | $11B | $10.3B | $11.7B | $14.1B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $15.2B | $17.3B | $16B | $18B | $21.5B | |
| Operating Income | $5.7B | $7.4B | $8.4B | $9.1B | $7.1B | |
| Net Interest Expenses | $1.1B | $1B | $1B | $913.6M | $770.2M | |
| EBT. Incl. Unusual Items | $6.5B | $5.6B | $7B | $7.5B | $4.4B | |
| Earnings of Discontinued Ops. | -- | $1.6B | $12.7B | -- | -- | |
| Income Tax Expense | $60M | $256.2M | $897.3M | $940.2M | $666.6M | |
| Net Income to Company | $6.5B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Minority Interest in Earnings | -$819.7M | -$457.7M | -$853.6M | -$471.1M | -$481.1M | |
| Net Income to Common Excl Extra Items | $7.3B | $5.6B | $18B | $6.1B | $3.3B | |
| Basic EPS (Cont. Ops) | $3.68 | $3.02 | $8.82 | $3.03 | $1.60 | |
| Diluted EPS (Cont. Ops) | $3.63 | $2.99 | $8.69 | $2.99 | $1.58 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $11.8B | $9.6B | $10.9B | $11.3B | $8.5B | |
| EBIT | $7.6B | $6.7B | $8.1B | $8.4B | $5.2B | |
| Revenue (Reported) | $31B | $37.1B | $36.2B | $37.7B | $40.1B | |
| Operating Income (Reported) | $5.7B | $7.4B | $8.4B | $9.1B | $7.1B | |
| Operating Income (Adjusted) | $7.6B | $6.7B | $8.1B | $8.4B | $5.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $37.1B | $36.2B | $37.7B | $40.1B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $12.3B | $11.9B | $10.7B | $11.6B | -- | |
| Gross Profit | $24.7B | $24.4B | $27.1B | $28.5B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $7B | $6.7B | $7.7B | $8.2B | -- | |
| Selling, General & Admin | $11B | $10.3B | $11.7B | $14.1B | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $17.3B | $16B | $18B | $21.5B | -- | |
| Operating Income | $7.4B | $8.4B | $9.1B | $7.1B | -- | |
| Net Interest Expenses | $1B | $1B | $913.6M | $770.2M | -- | |
| EBT. Incl. Unusual Items | $5.6B | $7B | $7.5B | $4.4B | -- | |
| Earnings of Discontinued Ops. | $1.6B | $12.7B | -- | -- | -- | |
| Income Tax Expense | $256.2M | $897.3M | $940.2M | $666.6M | -- | |
| Net Income to Company | $4.8B | $6.1B | $6.6B | $3.8B | -- | |
| Minority Interest in Earnings | -$457.7M | -$853.6M | -$471.1M | -$481.1M | -- | |
| Net Income to Common Excl Extra Items | $5.6B | $18B | $6.1B | $3.3B | -- | |
| Basic EPS (Cont. Ops) | $3.02 | $8.82 | $3.03 | $1.60 | -- | |
| Diluted EPS (Cont. Ops) | $2.99 | $8.69 | $2.99 | $1.58 | -- | |
| Weighted Average Basic Share | $8B | $8.6B | $8.1B | $8.2B | -- | |
| Weighted Average Diluted Share | $8.1B | $8.7B | $8.2B | $8.3B | -- | |
| EBITDA | $9.6B | $10.9B | $11.3B | $8.5B | -- | |
| EBIT | $6.7B | $8.1B | $8.4B | $5.2B | -- | |
| Revenue (Reported) | $37.1B | $36.2B | $37.7B | $40.1B | -- | |
| Operating Income (Reported) | $7.4B | $8.4B | $9.1B | $7.1B | -- | |
| Operating Income (Adjusted) | $6.7B | $8.1B | $8.4B | $5.2B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3B | $5.5B | $4.3B | $3.5B | $4.6B | |
| Short Term Investments | $106.3M | $82.3M | $5B | $2.9B | $26.4M | |
| Accounts Receivable, Net | $7.6B | $8.4B | $6.6B | $7.5B | $7B | |
| Inventory | $8.2B | $7.8B | $6.2B | $7B | $7.1B | |
| Prepaid Expenses | $489.3M | $425.1M | $415.1M | $452.2M | $489.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $27.6B | $25.2B | $25.1B | $23.8B | $21.3B | |
| Property Plant And Equipment | $15B | $14.4B | $11.6B | $12.7B | $12.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $14.4B | $14.2B | $8.5B | $8.7B | $8.8B | |
| Other Intangibles | $40.6B | $40.6B | $17.3B | $18.8B | $19.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | $2.4B | |
| Total Assets | $109.6B | $106.8B | $72.8B | $75.2B | $74.6B | |
| Accounts Payable | $5.9B | $6.1B | $4.7B | $4.7B | $4.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $313.5M | $274M | $202.1M | $198.7M | $210.8M | |
| Other Current Liabilities | $1B | $1.3B | $1.6B | $1.3B | $1.5B | |
| Total Current Liabilities | $30.2B | $31.9B | $27.6B | $26.8B | $27.2B | |
| Long-Term Debt | $30.7B | $26.7B | $19.6B | $18B | $17.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $81.3B | $78B | $60.6B | $58.9B | $58.2B | |
| Common Stock | $1.8B | $1.8B | $1.6B | $1.7B | $1.7B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $19.9B | $20.3B | $12.8B | $17B | $17.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.5B | $8.5B | -$607.5M | -$703.2M | -$734.1M | |
| Total Equity | $28.4B | $28.8B | $12.2B | $16.3B | $16.4B | |
| Total Liabilities and Equity | $109.6B | $106.8B | $72.8B | $75.2B | $74.6B | |
| Cash and Short Terms | $8.4B | $5.6B | $9.3B | $6.4B | $4.7B | |
| Total Debt | $35.5B | $31.3B | $24.2B | $21.4B | $19.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3B | $5.5B | $4.3B | $3.5B | $4.6B | |
| Short Term Investments | $106.3M | $82.3M | $5B | $2.9B | $26.4M | |
| Accounts Receivable, Net | $7.6B | $8.4B | $6.6B | $7.5B | $7B | |
| Inventory | $8.2B | $7.8B | $6.2B | $7B | $7.1B | |
| Prepaid Expenses | $489.3M | $425.1M | $415.1M | $452.2M | $489.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $27.6B | $25.2B | $25.1B | $23.8B | $21.3B | |
| Property Plant And Equipment | $15B | $14.4B | $11.6B | $12.7B | $12.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $14.4B | $14.2B | $8.5B | $8.7B | $8.8B | |
| Other Intangibles | $40.6B | $40.6B | $17.3B | $18.8B | $19.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | $2.4B | |
| Total Assets | $109.6B | $106.8B | $72.8B | $75.2B | $74.6B | |
| Accounts Payable | $5.9B | $6.1B | $4.7B | $4.7B | $4.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $313.5M | $274M | $202.1M | $198.7M | $210.8M | |
| Other Current Liabilities | $1B | $1.3B | $1.6B | $1.3B | $1.5B | |
| Total Current Liabilities | $30.2B | $31.9B | $27.6B | $26.8B | $27.2B | |
| Long-Term Debt | $30.7B | $26.7B | $19.6B | $18B | $17.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $81.3B | $78B | $60.6B | $58.9B | $58.2B | |
| Common Stock | $1.8B | $1.8B | $1.6B | $1.7B | $1.7B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.5B | $8.5B | -$607.5M | -$703.2M | -$734.1M | |
| Total Equity | $28.4B | $28.8B | $12.2B | $16.3B | $16.4B | |
| Total Liabilities and Equity | $109.6B | $106.8B | $72.8B | $75.2B | $74.6B | |
| Cash and Short Terms | $8.4B | $5.6B | $9.3B | $6.4B | $4.7B | |
| Total Debt | $35.5B | $31.3B | $24.2B | $21.4B | $19.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.5B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Depreciation & Amoritzation | $2.6B | $2.9B | $2.7B | $2.9B | $3.3B | |
| Stock-Based Compensation | $432.5M | $471.9M | $428.5M | $382M | $439.6M | |
| Change in Accounts Receivable | -$806M | -$1.6B | -$762.8M | -$807.6M | $434.5M | |
| Change in Inventories | $128.3M | $70.2M | -$333.1M | -$527.6M | -$375.7M | |
| Cash From Operations | $10.8B | $10.9B | $9.2B | $8.4B | $8.4B | |
| Capital Expenditures | $2.5B | $3.7B | $2.8B | $2.9B | $3.8B | |
| Cash Acquisitions | $3.7B | $254.5M | -$3.9B | $362.1M | $1.7B | |
| Cash From Investing | $2.8B | -$2.4B | -$10.9B | -$2B | -$1.6B | |
| Dividends Paid (Ex Special Dividend) | -$5.1B | -$5.5B | -$4.3B | -$2.8B | -$3.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.2B | $414.1M | $2.5B | $277.5M | $1.7B | |
| Long-Term Debt Repaid | -$9.4B | -$3.2B | -$8.3B | -$3.2B | -$3.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$866.3M | -$572.3M | $13B | $424.3M | $176.4M | |
| Cash From Financing | -$13B | -$10.4B | $1B | -$7B | -$6B | |
| Beginning Cash (CF) | $6.2B | $7.2B | $4.7B | $4.3B | $3.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $603.2M | -$1.9B | -$676.1M | -$582.3M | $765.5M | |
| Ending Cash (CF) | $6.8B | $5.3B | $4.2B | $3.6B | $4.3B | |
| Levered Free Cash Flow | $8.3B | $7.3B | $6.4B | $5.5B | $4.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$621.2M | $568.4M | $2.2B | $387.5M | $583.5M | |
| Depreciation & Amoritzation | $3.1B | $416.8M | -$37.6M | $738.6M | $476.9M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $4.9B | $5.2B | $2.7B | $3.9B | $2.9B | |
| Capital Expenditures | $694.9M | $746.1M | $1B | $940.1M | $1.4B | |
| Cash Acquisitions | -$74.2M | -$46.1M | -$199.7M | $1.2B | -$156.6M | |
| Cash From Investing | -$86.2M | -$492.3M | -$1.2B | $374.3M | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.3B | -$982.6M | -$669.9M | -$739.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.2B | $414.1M | $1.6B | -$1.8B | $1.7B | |
| Long-Term Debt Repaid | -$1.9B | -$2.4B | -$2.3B | -$1.7B | -$1.4B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.2B | -$1.5M | $936.5M | $192.6M | -$59.2M | |
| Cash From Financing | -$2.7B | -$3.8B | -$1.5B | -$4.4B | -$986M | |
| Beginning Cash (CF) | $4.7B | $4.4B | $3.9B | $3.8B | $3.9B | |
| Foreign Exchange Rate Adjustment | -$28.1M | -$10.9M | $63.5M | -$40.9M | $10.4M | |
| Additions / Reductions | $2.1B | $875.7M | -$1.8M | -$151.8M | $465M | |
| Ending Cash (CF) | $6.8B | $5.3B | $4.2B | $3.6B | $4.3B | |
| Levered Free Cash Flow | $4.2B | $4.4B | $1.7B | $3B | $1.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.5B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Depreciation & Amoritzation | $2.6B | $2.9B | $2.7B | $2.9B | $3.3B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.8B | $10.9B | $9.2B | $8.4B | $8.4B | |
| Capital Expenditures | $2.5B | $3.7B | $2.8B | $2.9B | $3.8B | |
| Cash Acquisitions | $3.7B | $254.5M | -$3.9B | $362.1M | $1.7B | |
| Cash From Investing | $2.8B | -$2.4B | -$10.9B | -$2B | -$1.6B | |
| Dividends Paid (Ex Special Dividend) | -$5.1B | -$5.5B | -$4.3B | -$2.8B | -$3.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9.4B | -$3.2B | -$8.3B | -$3.2B | -$3.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$866.3M | -$572.3M | $13B | $424.3M | $176.4M | |
| Cash From Financing | -$13B | -$10.4B | $1B | -$7B | -$6B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $603.2M | -$1.9B | -$676.1M | -$582.3M | $765.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $8.3B | $7.3B | $6.4B | $5.5B | $4.6B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.8B | $6.1B | $6.6B | $3.8B | -- | |
| Depreciation & Amoritzation | $2.9B | $2.7B | $2.9B | $3.3B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.9B | $9.2B | $8.4B | $8.4B | -- | |
| Capital Expenditures | $3.7B | $2.8B | $2.9B | $3.8B | -- | |
| Cash Acquisitions | $254.5M | -$3.9B | $362.1M | $1.7B | -- | |
| Cash From Investing | -$2.4B | -$10.9B | -$2B | -$1.6B | -- | |
| Dividends Paid (Ex Special Dividend) | -$5.5B | -$4.3B | -$2.8B | -$3.1B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $414.1M | $2.5B | $277.5M | $1.7B | -- | |
| Long-Term Debt Repaid | -$3.2B | -$8.3B | -$3.2B | -$3.2B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$572.3M | $13B | $424.3M | $176.4M | -- | |
| Cash From Financing | -$10.4B | $1B | -$7B | -$6B | -- | |
| Beginning Cash (CF) | $21.8B | $32.8B | $15.1B | $14.5B | -- | |
| Foreign Exchange Rate Adjustment | -$39.9M | $188.2M | -$123.2M | -$69M | -- | |
| Additions / Reductions | -$1.9B | -$676.1M | -$582.3M | $765.5M | -- | |
| Ending Cash (CF) | $19.8B | $31.9B | $14.5B | $15.2B | -- | |
| Levered Free Cash Flow | $7.3B | $6.4B | $5.5B | $4.6B | -- | |
Get GSK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GSK
Sector
P/E ratio
24.94x
24.08x
PEG ratio
--
0.00x
P/B ratio
4.69x
1.70x
Price / LTM sales
2.04x
1.69x
Growth Metrics
GSK
Sector
Revenue growth
3.92%
6.61%
Earnings growth
21.28%
6.3%
Revenue (5-year growth)
-1.43%
9.15%
Earnings forecast
$0.49
-$0.19
Profitability
GSK
Sector
Profitability FY 2024
$28.5B
$57.2M
Return on invested capital
8.51%
-14.96%
Return on assets
4.35%
-12.41%
Return on equity
19.22%
-17.27%
Earnings Date
Last Earnings Date
Feb
5
Next Earnings Date
Apr
30
Estimated Next Earnings Date
May
7
Balance Sheet
GSK
Sector
Total cash
$4.7B
$43.2M
Short term investments
$26.4M
$39.2M
Total assets
$74.6B
$129.9M
Long term debt
$19.9B
$9.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is Buffett Buying and Selling Now?
In Q4 of last year, Warren Buffett made a few…
3 Safest Stocks to Buy Now
With the S&P 500 now in correction and stocks selling…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
59
GRRR alert for Mar 15
Gorilla Technology Group [GRRR] is up 29.72% over the past day.
Sell
49
SMTC alert for Mar 15
Semtech [SMTC] is up 21.28% over the past day.
Buy
62
PLPC alert for Mar 15
Preformed Line Products [PLPC] is up 17.38% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
